News & Publications

© 2016 BD. All rights reserved. Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson and Company.

Cellular Research Launches Grant Program for a Free Single Cell Gene Expression Project

PALO ALTO, Calif., USA – August 06, 2015 – Cellular Research, Inc., today announced the company has launched a grant program to give researchers the chance to access its Precise assay technology for an RNA-seq project on up to 1,000 cells for free.

Based on Cellular Research’s patented Molecular Indexing™ technology, the Precise assays offer absolute quantitation and bias-free expression information. The assays allow the examination of large numbers of standard or low-input mRNA samples from precious samples, or whenever absolute quantitation is required. The Precise assays combine molecular and sample indexing in 96- and 384-sample formats, enabling customers to sequence up to 4,608 samples on one sequencing run without investment in new equipment or extensive training.

“Progress in single cell gene expression research has been limited by inadequate sample throughput, expensive library prep and sequencing, and limited sample sensitivity, and our Precise Assays address these challenges,” said Martin Pieprzyk, Director of Strategic Marketing for Cellular Research. “We are sponsoring this grant program to increase awareness about how affordable single cell gene expression can be with our optimized, high-throughput workflow that offers the lowest cost-per-sample, and the opportunity for one scientist to try it for free.”

Interested parties can access more information about the grant program, including an application form, by visiting: http://www.cellular-research.com/scgrantprogram/.

About Cellular Research
Cellular Research, Inc. is a biotechnology research and development company founded by innovators from Silicon Valley and Stanford University. Our mission is to develop and commercialize a new generation of highly sensitive life science technologies and products. In addition to introducing a portfolio of research products, the Company has an active partnership program with pharmaceutical and diagnostics companies advancing clinical applications. For more information, please visit http://www.cellular-research.com/ and follow us on Twitter @Cell_Research.

Media Contact:
Nicole Litchfield
Bioscribe Inc., for Cellular Research
415-793-6468
Nicole@bioscribe.com
Back to overview